Current Report Filing (8-k)
May 05 2016 - 8:02AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant
to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 4, 2016
KINDRED HEALTHCARE, INC.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
001-14057
|
|
61-1323993
|
(State or other jurisdiction of
incorporation or organization)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
680 South Fourth Street
Louisville, Kentucky
(Address of principal executive offices)
40202
(Zip Code)
Registrants telephone number, including area code: (502) 596-7300
Not Applicable
(Former
name or former address, if changed since last report)
Check the appropriate box below
if the Form 8-K filing is intended to simultaneously satisfy the filing obligation to the registrant under any of the following provisions:
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 2.02.
|
Results of Operations and Financial Condition.
|
On May 4, 2016, Kindred Healthcare, Inc.
(the Company) issued a press release announcing its financial results for the first quarter ended March 31, 2016. The press release, dated May 4, 2016, is attached as Exhibit 99.1 to this Form 8-K. On May 4, 2016, the Company also made
the press release available on its website at
www.kindredhealthcare.com
.
The information contained herein is being furnished
pursuant to Item 2.02 of Form 8-K, Results of Operations and Financial Condition. This information shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the
Exchange Act), or incorporated by reference in any filing under the Securities Act of 1933, as amended (the Securities Act), or the Exchange Act, nor shall this information be deemed incorporated by reference into any filing
made by the Company under the Securities Act or the Exchange Act, except as expressly set forth by specific reference in such a filing.
Item 7.01.
|
Regulation FD Disclosure.
|
Incorporated by reference is Exhibit 99.1 attached hereto, a
press release issued by the Company on May 4, 2016 announcing its financial results for the first quarter ended March 31, 2016. This information is being furnished under Item 7.01 and shall not be deemed filed for purposes of
Section 18 of the Exchange Act, or otherwise subject to the liability of such section nor shall this information be deemed incorporated by reference into any filing made by the Company under the Securities Act or the Exchange Act, except as
expressly set forth by specific reference in such a filing.
On May 4, 2016, the Company issued an additional press release announcing
that its Board of Directors approved the payment of a cash dividend to its common shareholders. A cash dividend of $0.12 per common share will be paid on June 10, 2016 to all common shareholders of record as of the close of business on May 18, 2016.
The press release also announced that the Companys Board of Directors approved the scheduled June 1, 2016 installment payment of $18.76 per share of the Companys Mandatory Redeemable Preferred Stock, Series A. The installment payment
will be paid on June 1, 2016 to the preferred shareholders of record as of 5:00 p.m., New York City time, on May 15, 2016. Future declarations of dividends and installment payments will be subject to the approval of the Companys Board of
Directors. A copy of the press release is attached hereto as Exhibit 99.2 and incorporated herein by reference.
Item 9.01.
|
Financial Statements and Exhibits.
|
(d) Exhibits
|
|
|
Exhibit 99.1
|
|
Press release (earnings) dated May 4, 2016.
|
|
|
Exhibit 99.2
|
|
Press release (dividend) dated May 4, 2016.
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
KINDRED HEALTHCARE, INC.
|
|
|
|
|
Date: May 5, 2016
|
|
|
|
By:
|
|
/s/ Joseph L. Landenwich
|
|
|
|
|
|
|
Joseph L. Landenwich
|
|
|
|
|
|
|
General Counsel and Corporate Secretary
|
EXHIBIT INDEX
|
|
|
Exhibit
|
|
Description
|
|
|
99.1
|
|
Press release (earnings) dated May 4, 2016.
|
|
|
99.2
|
|
Press release (dividend) dated May 4, 2016.
|
Kindred Healthcare (NYSE:KND)
Historical Stock Chart
From Mar 2024 to Apr 2024
Kindred Healthcare (NYSE:KND)
Historical Stock Chart
From Apr 2023 to Apr 2024